Third Quarter 2026 Earnings Conference Call - HEALTHSTREAM INC

Financial Performance:

• Q3 2026 revenue reached $83.3 million, an 8.9% year-over-year increase, with full-year YTD revenue up 10.6% to $248.2 million.
• Adjusted EBITDA for the quarter was $19.3 million (23.2% margin), slightly up 1% YoY, outperforming the 22% forecast; YTD adjusted EBITDA was $60 million (up 13.4%).
• Net income was $5.4 million (down 11.7% YoY) and operating income was $6.6 million (down 13% YoY), impacted by higher operating expenses.
• Free cash flow for the year-to-date was $34.7 million (up 40% YoY), while Q3 gross margin declined to 64% from 65.3% due to labor, hosting, and software costs.
• Balance sheet strengthened significantly with cash and marketable securities totaling $115.2 million and zero debt; a $40 million private placement closed in September at $29.50/share.
• Remaining Performance Obligations (RPO) stood at $686 million (up from $621 million), with 41% expected to convert to revenue in the next 12 months.

Guidance and Future Outlook:

• Raised full-year 2026 guidance: Revenue expected at $331–$333 million, net income at $21.8–$22.4 million, and adjusted EBITDA at $77–$78 million.
• Q4 revenue growth is forecasted at 4–6%, with adjusted EBITDA margins expected to approximate 21% due to seasonal trade show expenses and cloud migration costs.
• Management anticipates lower organic growth in Q4 as prior-year acquisitions provide higher YoY comparables.
• Long-term outlook remains positive, driven by AI integration, platform expansion, and the shift toward integrated "suite" solutions.

Business Segments and Product Lines:

• Subscription product revenue grew 8% organically, led by "My Clinical Exchange" (+34%), "Shift Wizard" (+20%), "Resuscitation Suite" (+14%), and "CredentialStream" (+15%).
• Inorganic growth contributed 4.2% via acquisitions (Versus 12 and Mission Care Collective); legacy and sunsetting products declined 15% to ~10% of total revenue.
• Strategic pivot to "programmatic suites" (Competency, Compliance, Resuscitation) aiming to consolidate point solutions into single enterprise contracts.
• Rebranding initiatives: "Shift Wizard" to HealthStream Scheduling, "CredentialStream" to Healthcare Credentialing, and "HealthStream Learning Center" to HealthStream Learning.
• AI capabilities are central to the platform, utilizing the "single verified clinician record" to enable personalized learning and competency assessments.

Market and Competitive Landscape:

• Customers are increasingly demanding holistic, vendor-consolidated solutions over fragmented point solutions, creating a favorable environment for HealthStream's suite strategy.
• The addressable market includes 13.7 million healthcare professionals and nursing students; nurse employment is projected to remain a strong growth engine, supporting seat expansion rather than reduction.
• HealthStream products are gaining third-party validation, ranking in the top three on G2 for 26 categories and achieving a Net Promoter Score increase from 36 to 69.
• The ecosystem now includes 441 customers using the developer portal with 890 registered users, facilitating API-driven integrations.

Risks and Challenges:

• Gross margin pressure expected over the next 3–4 quarters due to the ongoing migration from on-premise data centers to AWS, involving overlapping costs and increased hosting expenses.
• Rising operating expenses driven by labor costs, stock-based compensation, and investments in sales and product development.
• Revenue decline from legacy and sunsetting products requires active management and customer migration to newer solutions.
• Integration of recent acquisitions (Versus 12, Mission Care) is proceeding, but management noted performance is "okay, not quite up to expectations," requiring further investment.

Management Commentary and Tone:

• Tone is confident and optimistic, emphasizing a "solid quarter" that supports a second consecutive guidance raise.
• Management highlighted the strategic strength of the balance sheet (no debt, strong cash) and the ecosystem's defensibility against new entrants.
• CEO Frist emphasized that AI is a tool to free caregivers from administrative tasks and that the unique data assets (13.7M users) provide a competitive moat.
• CFO Roberts reiterated a disciplined capital allocation priority: organic investment first, followed by M&A, dividends, and share repurchases.

Analyst Questions and Answers:

• Bundling Strategy: Confirmed sales organization is shifting to lead with suites/bundles; this may lengthen cycles for large enterprise deals but offers compelling value via vendor consolidation.
• M&A Capability: Strong balance sheet and platform maturity expand the scope of potential acquisitions to include PaaS partners and modern tech integrations, not just traditional point solutions.
• Gross Margins: Management expects short-term margin drag (3-4 quarters) during the AWS migration, with long-term benefits from efficiency and lower costs.
• Legacy Products: Defined "sunsetting" vs. "legacy" products; legacy products are ~10% of revenue, and management plans to accelerate migration off these platforms over the next 4–8 quarters.
• AI Workforce Impact: AI may reduce administrative burdens, but demand for training and competency validation remains high; tools like "Jane AI" are critical for assessing clinical reasoning.

Other Key Points:

• Announced a quarterly cash dividend of $0.035 per share, payable November 27.
• Repurchased $9.3 million of common stock in the first nine months of 2026.
• The "Innovation Council" meeting in October involved 65 leaders from major health systems (e.g., Kaiser, Cleveland Clinic) to co-develop product roadmaps.
• My Clinical Exchange reached 219,000 unique student users, creating 123,000 new H-Stream IDs, effectively capturing the pipeline of future clinicians.